During the reporting period, BonePainIII made coordinated scientific progress toward understanding bone pain and developing improved research tools. Across the five scientific and training Work Packages, the network focused on building human‑relevant laboratory models, exploring biological mechanisms of pain, testing early concepts in preclinical models, and linking experimental findings to initial observations from patient‑derived material. These activities collectively form the technical foundation required for future discovery and translation.
WP1 concentrated on creating advanced cell‑based and engineered systems to mimic conditions relevant to bone pain. Partners established the necessary laboratory infrastructure and developed early versions of human‑based models that allow controlled study of interactions between different cell types involved in pain.
WP2 investigated key biological processes thought to contribute to pain across several bone‑related diseases. Work focused on establishing experimental approaches that can help identify important pathways, cell types, or molecular signals, using both laboratory models and insights from human samples.
WP3 further developed and refined preclinical pain models that can be used to study disease‑related changes. These models were prepared for assessing potential therapeutic strategies and were aligned with laboratory and clinical insights to ensure consistency across research stages.
WP4 strengthened the translational link by examining human tissue and fluid samples to identify patterns that may help explain differences in pain experiences. Early laboratory work using human‑derived cells supported the development of models that more closely reflect clinical biology.
WP5 ensured that Doctoral Candidates received high‑quality scientific training, enabling them to carry out the technical work described above and contribute effectively to the project’s long‑term goals.
Overall, the project has successfully established the experimental, conceptual, and training framework needed to investigate mechanisms of bone pain. These achievements prepare the consortium for deeper mechanistic studies and future evaluation of potential therapeutic approaches in the next phase.
